Total Payments
$31,152
2024 Payments
$170.03
Companies
16
Transactions
77
Medicare Patients
23,011
Medicare Billing
$16.9M
Payment Breakdown by Category
Other$28,615 (91.9%)
Food & Beverage$2,536 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $16,629 | 1 | 53.4% |
| Current or prospective ownership or investment interest | $11,986 | 6 | 38.5% |
| Food and Beverage | $2,536 | 63 | 8.1% |
| Unspecified | $0 | 7 | 0.0% |
Payments by Type
General
$31,152
70 transactions
Ownership
$0
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $28,615 | 14 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $750.16 | 22 | $0 (2024) |
| Alimera Sciences, Inc. | $534.53 | 6 | $0 (2022) |
| Genentech USA, Inc. | $310.66 | 13 | $0 (2024) |
| Allergan Inc. | $221.16 | 3 | $0 (2018) |
| Astellas Pharma US Inc | $152.93 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $142.97 | 3 | $0 (2018) |
| ABBVIE INC. | $118.37 | 2 | $0 (2022) |
| Apellis Pharmaceuticals, Inc. | $97.22 | 4 | $0 (2024) |
| Lilly USA, LLC | $90.70 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170.03 | 6 | Genentech USA, Inc. ($57.40) |
| 2023 | $17,150 | 15 | US Retina LLC ($16,629) |
| 2022 | $4,983 | 15 | US Retina LLC ($4,647) |
| 2021 | $4,092 | 7 | US Retina LLC ($4,000) |
| 2020 | $1,535 | 3 | US Retina LLC ($1,445) |
| 2019 | $2,152 | 8 | US Retina LLC ($1,895) |
| 2018 | $563.85 | 12 | Alimera Sciences, Inc. ($228.98) |
| 2017 | $505.73 | 11 | Allergan Inc. ($210.62) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: OPTOMETRY | ||||||
| 11/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Ophthalmology | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $122.49 | General |
| Category: Ophthalmology | ||||||
| 11/21/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.44 | General |
| 11/15/2023 | US Retina LLC | — | Acquisitions | Cash or cash equivalent | $16,629.00 | General |
| 11/13/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: Ophthalmology | ||||||
| 10/25/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $94.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/10/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Ophthalmology | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/25/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/13/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $80.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/19/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $27.27 | General |
| Category: Ophthalmology | ||||||
| 02/28/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/10/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/09/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 2023 | US Retina LLC | — | — | — | $0.00 | Ownership |
| 12/20/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/01/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $78.66 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 5,793 | 45,548 | $10.8M | $4.6M |
| 2022 | 24 | 6,056 | 19,585 | $9.9M | $4.2M |
| 2021 | 23 | 5,446 | 16,798 | $9.1M | $4.0M |
| 2020 | 21 | 5,716 | 17,358 | $9.5M | $4.1M |
Total Patients
23,011
Total Services
99,289
Medicare Billing
$16.9M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 401 | 4,166 | $6.2M | $2.9M | 46.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 110 | 27,660 | $1.7M | $802,179 | 48.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 508 | 2,762 | $1.0M | $234,755 | 23.4% |
| 92134 | Imaging of retina | Office | 2023 | 1,227 | 3,844 | $384,400 | $112,949 | 29.4% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 38 | 900 | $180,000 | $108,325 | 60.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 30 | 505 | $313,100 | $94,535 | 30.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 771 | 1,070 | $197,950 | $93,813 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 468 | 1,014 | $187,590 | $65,435 | 34.9% |
| J3490 | Unclassified drugs | Office | 2023 | 20 | 32 | $96,000 | $57,294 | 59.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 1,191 | 2,414 | $193,120 | $27,713 | 14.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 135 | 135 | $30,375 | $13,910 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $34,800 | $12,872 | 37.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 184 | 192 | $26,880 | $12,013 | 44.7% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 13 | 13 | $39,000 | $11,446 | 29.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 145 | 173 | $21,625 | $7,113 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 79 | $15,800 | $6,586 | 41.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 68 | 68 | $17,952 | $6,284 | 35.0% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 12 | 22 | $33,000 | $5,613 | 17.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 17 | 59 | $14,750 | $3,005 | 20.4% |
| 92250 | Photography of the retina | Office | 2023 | 101 | 104 | $20,800 | $2,755 | 13.2% |
| 67141 | Heat or freezing treatment to prevent detachment of retina | Office | 2023 | 15 | 15 | $21,600 | $2,574 | 11.9% |
| 68200 | Injection into conjunctiva | Office | 2023 | 44 | 88 | $27,590 | $1,430 | 5.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 29 | $8,613 | $1,051 | 12.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 55 | 60 | $4,800 | $868.14 | 18.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 15 | $2,400 | $587.64 | 24.5% |
About Dr. Mohit Nanda, MD
Dr. Mohit Nanda, MD is a Ophthalmology healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750363396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohit Nanda, MD has received a total of $31,152 in payments from pharmaceutical and medical device companies, with $170.03 received in 2024. These payments were reported across 77 transactions from 16 companies. The most common payment nature is "Acquisitions" ($16,629).
As a Medicare-enrolled provider, Nanda has provided services to 23,011 Medicare beneficiaries, totaling 99,289 services with total Medicare billing of $16.9M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Charlottesville, VA
- Active Since 11/18/2005
- Last Updated 06/25/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1750363396
Products in Payments
- EYLEA (Biological) $373.57
- EYLEA AFLIBERCEPT INJECTION (Biological) $267.50
- OZURDEX (Drug) $235.71
- Vabysmo (Drug) $190.09
- ILUVIEN (Drug) $180.45
- Iluvien (Drug) $125.10
- Izervay (Drug) $122.49
- Humira (Biological) $103.82
- Lucentis (Biological) $102.59
- TRAVATAN Z (Drug) $99.45
- Syfovre (Drug) $97.22
- TALTZ (Drug) $90.70
- EYLEA HD (Biological) $84.93
- BROLUCIZUMAB (Drug) $43.52
- IHEEZO (Drug) $32.14
- Thera Skin (Biological) $25.00
- LIBTAYO (Biological) $24.16
- VABYSMO (Drug) $17.98
- KEYTRUDA (Biological) $16.99
- PICATO (Drug) $15.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Charlottesville
Dr. Marc Odrich, M.d, M.D
Ophthalmology — Payments: $1.3M
Ophthalmology $1.3M
Jayakrishna Ambati, Md, MD
Ophthalmology — Payments: $355,360
Ophthalmology $355,360
Michael Grant, M.d, M.D
Ophthalmology — Payments: $209,506
Ophthalmology $209,506
Maria Kirzhner, M.d, M.D
Ophthalmology — Payments: $58,735
Ophthalmology $58,735
Peter Netland, Md, MD
Ophthalmology — Payments: $35,884
Ophthalmology $35,884
Albert Jun, M.d, M.D
Ophthalmology — Payments: $28,547
Ophthalmology $28,547